Monto, Almaida .

HRN: 11-70-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2023
CEFUROXIME 500MG (TAB)
11/21/2023
11/28/2023
PO
500mg
BID
Rmle
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: